Literature DB >> 2856284

A detailed study of cytomegalovirus infections in the first 160 heart and heart/lung transplant recipients at Papworth Hospital, Cambridge, England.

T G Wreghitt1, M Hakim, J J Gray, S Kucia, R Cory-Pearce, J Wallwork, T A English.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2856284

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.

Authors:  T C Wu; R H Hruban; R F Ambinder; M Pizzorno; D E Cameron; W A Baumgartner; B A Reitz; G S Hayward; G M Hutchins
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

2.  Viral and toxoplasma gondii infections in children after liver transplantation.

Authors:  A Salt; G Sutehall; M Sargaison; C Woodward; N D Barnes; R Y Calne; T G Wreghitt
Journal:  J Clin Pathol       Date:  1990-01       Impact factor: 3.411

3.  Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation.

Authors:  G J Boland; R J Hene; C Ververs; M A de Haan; G C de Gast
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

4.  Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience.

Authors:  A H Balk; W Weimar; P H Rothbarth; K Meeter; H J Metselaar; B Mochtar; M L Simoons
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

5.  Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation.

Authors:  N G Best; A K Trull; K K Tan; K L Hue; D J Spiegelhalter; S M Gore; J Wallwork
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.